These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6892799

  • 1. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
    Beamer WG, Wilson MC, DeLuca HF.
    Endocrinology; 1980 Jun; 106(6):1949-55. PubMed ID: 6892799
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 3. Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse.
    Marie PJ, Travers R, Glorieux FH.
    Calcif Tissue Int; 1982 Mar; 34(2):158-64. PubMed ID: 6282410
    [Abstract] [Full Text] [Related]

  • 4. Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse.
    Tenenhouse HS, Scriver CR.
    Endocrinology; 1981 Aug; 109(2):658-60. PubMed ID: 6894727
    [Abstract] [Full Text] [Related]

  • 5. Lack of effect of vitamin D and its metabolites on intestinal phosphate transport in familial hypophosphatemia of mice.
    O'Doherty PJ, DeLuca HF, Eicher EM.
    Endocrinology; 1977 Oct; 101(4):1325-30. PubMed ID: 908280
    [Abstract] [Full Text] [Related]

  • 6. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF.
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE.
    N Engl J Med; 1980 Oct 30; 303(18):1023-31. PubMed ID: 6252463
    [Abstract] [Full Text] [Related]

  • 9. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E, Kuroda Y, Saijo T, Naito E, Kobashi H, Yokota I, Miyao M.
    Pediatrics; 1987 Jul 30; 80(1):97-101. PubMed ID: 3037475
    [Abstract] [Full Text] [Related]

  • 10. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
    Hirschman GH, DeLuca HF, Chan JC.
    Pediatrics; 1978 Mar 30; 61(3):451-7. PubMed ID: 25411
    [Abstract] [Full Text] [Related]

  • 11. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B, Glorieux FH, Desbarats M, Travers R, Labelle L.
    J Bone Miner Res; 1995 Mar 30; 10(3):424-31. PubMed ID: 7785464
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets.
    Tenenhouse HS, Yip A, Jones G.
    J Clin Invest; 1988 Feb 30; 81(2):461-5. PubMed ID: 3339128
    [Abstract] [Full Text] [Related]

  • 15. The mobilization of bone mineral by 1,25-dihydroxyvitamin D3 in hypophosphatemic rats.
    Castillo L, Tanaka Y, DeLuca HF.
    Endocrinology; 1975 Oct 30; 97(4):995-9. PubMed ID: 1193018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal 24-hydroxylation of 25-hydroxyvitamin D in the X-linked hypophosphatemic mouse.
    Cunningham J, Gomes H, Seino Y, Chase LR.
    Endocrinology; 1983 Feb 30; 112(2):633-8. PubMed ID: 6600222
    [Abstract] [Full Text] [Related]

  • 18. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
    Meyer MH, Meyer RA.
    J Bone Miner Res; 1988 Apr 30; 3(2):151-7. PubMed ID: 3213610
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E, Yokota I, Saijo T, Kawakami I, Ito M, Kuroda Y.
    Acta Paediatr Jpn; 1990 Feb 30; 32(1):39-43. PubMed ID: 2158205
    [Abstract] [Full Text] [Related]

  • 20. Normal regulation of calcitriol production in Gy mice. Evidence for biochemical heterogeneity in the X-linked hypophosphatemic diseases.
    Davidai GA, Nesbitt T, Drezner MK.
    J Clin Invest; 1990 Feb 30; 85(2):334-9. PubMed ID: 2153705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.